Overview
Status
Active
Registry date
2016-11-16
Share capital
17,800.00 PLN
Registered address
ul. Domaniewska 47/10, 02-672 Warszawa, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 665 days for 2023).
- 2025filed
- 202415/07/2025
- 202311/05/2026
- 202220/07/2023
- 202123/11/2022
- 202030/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Piotr Krukowski – Management Board Member
Marek Piotr Redzimski – Management Board Member
Manner of representation
Each member of the management board has the right to represent the company independently.
Supervisory board
Szymon Andrzej Syp – Supervisory Board Member
Łukasz Bukowski – Supervisory Board Member
Paweł Osiakowski – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Krukowskiage 34 | 102 | $1,377.63 | 28.6517% |
| 44 | $594.27 | 12.3596% | |
Pro Bono Fundusz Inwestycyjny Zamknięty | 88 | $1,188.55 | 24.7191% |
Maciej Szurekage 48 | 101 | $1,364.13 | 28.3708% |
Others | 21 | $283.63 | 5.8988% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-12-15.
12 1090 1043 0000 0001 3467 7666
Debt
1 closed proceeding recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Dec 3, 2024 | Discontinued enforcement proceedings | Closed |
Public aid
7 public aid cases recorded, with a total value of $2,090,748.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 28, 2019 | Aid for research and development projects: industrial research | $1.2M$1,198,486 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 28, 2019 | Aid for research and development projects: experimental development | $633.5K$633,495 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-11-01 | 879510 - Pluto - one-of-a-kind therapy for crossed eyes. helping families to reduce emotional and financial burden of eye therapy. | $2.2M$2,168,481 | 1.1.31 - Horizon 2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Poldentsp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Metzer Medizin- Und Industrietechniksp. z o.o. | $1,511,723.18 | metzer.pl | ||
| Endotradesp. z o.o. | $912,862.33 | endotrade.pl | ||
| PhilabsS.A. | $64,403.10 | phibox.eu | ||
| IDL Polandsp. z o.o. | $43,351.03 | idlpoland.com | ||
| Milton EssexS.A. | $40,863.48 | miltonessex.eu | ||
| NEO Ortho Pracownia Sztuki Ortopedycznejsp. z o.o. | $5,662.74 | neoortho.pl | ||
| Bioimplantisp. z o.o. | $1,660.39 | bioimplanti.pl | ||
| Genvitasp. z o.o. | $0.00 | genvita.com.pl | ||
| Noris Dental Implants Solutionssp. z o.o. | – | norismedical.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-10-28 | Share capital increase (7,200.00 PLN → 17,800.00 PLN) | |
| 2019-07-11 | Share capital increase (6,100.00 PLN → 7,200.00 PLN) | |
| 2018-03-19 | Share capital increase (5,000.00 PLN → 6,100.00 PLN) | |
| 2018-03-19 | PKD change (Removed: 1 code; Added: 10 codes) | |
| 2016-11-16 | Entered in the register |
FAQ
Last updated: 2026-05-11